The coenzyme A thiol ester of ricinoleic acid was synthesized and characterized.
INTRODUCTION
Several nutritional studies have focused upon the fate of ingested ricinoleic acidl-4. When ricinoleic acid or triricinolein is fed to rats, the acid can be absorbed and activated to ricinoleoyl-CoA3 and subsequently incorporated into fat pad triglycerides1-4. Depending on the nature and duration of the diet, some 5-107~ of the fatty acids in the carcass triglyceride can be shown to be ricinoleic acid'-4. In spite of this rather heavy accumulation in triglycerides, no ricinoleate is incorporated into tissue phospholipids1-4. WATSON AND MURRAY~ report that "The absence of ricinoleic acid (in phospholipids) is absolute. Excessively large samples were analysed deliberately and no trace of ricinoleic acid was found". On the basis of these results they suggested that the incorporation of ricinoleate into triglyceride may proceed via the acylation of monoglycerideSpB rather than via the de nova or phosphatidic acid pathway'-9.
In view of the fact that ricinoleate appears to be completely excluded from mammalian phospholipids in vivo, we thought that a direct examination of the acyltransferase systems in vitro might help explain the exact mechanism of this exclusion. The purpose of this communication is to report the results of experiments in which ricinoleoyl-CoA has been synthesized, characterized and tested as a substrate for various rat liver microsomal acyltransferaseslo*ll. 
MATERIALS AND METHODS

Reagents
Ricinoleic acid (xz-hydroxy-octadec-g-enoic acid) was purchased from the Hormel Institute and used without further purification. Coenzyme A was a product of Calbiochem. Silicic acid (200-325 mesh) and Silica Gel G chromatography resins were purchased from Mallinkrodt and Brinkmann, respectively. Bis-(trimethylsilyl-)-trifluoroacetamide (Regisil) was obtained from the Regis Chemical Company. 5,5'-Dithiobis-(2nitrobenzoic acid) (DTNB) was a product of Aldrich Chemical Company while ethyl chloroformate was purchased from Eastman Organic Chemicals. All other solvents and reagents were obtained from commercial sources and used without further purification.
Synthesis of ricinoleoyl-Cod
Ricinoleoyl-CoA was synthesized using the mixed anhydride procedure described by KASS et a1.12.
I mmole of ricinoleic acid was dissolved in 20 ml of tetrahydrofuran (distilled over LiAIH, immediately before use) and treated with I mmole each of triethylamine and ethyl chloroformate at 2'. After I h, the resulting suspension was filtered and washed with tetrahydrofuran. The solution was evaporated and the residue dissolved in z ml of tetrahydrofuran. This solution was added slowly to a solution of 33 pmoles of coenzyme A (Li-salt} in 5 ml of tetrahydrofuran-water (5:2, v/v) ; the pH being adjusted to 7.5 after each addition. The reaction was judged complete when an aliquot of the reaction mixture failed to produce a yellow color when added to I mM DTNB in 0.1 M Tris-HCl buffer (pH 7.4).
After removal of tetrahydrofuran under vacuum, ricinoleoyl-Cob was precipitated by adjusting the solution to 1% HClO,. The aqueous suspension was extracted several times with diethyl ether and the precipitate was finally collected by centrifugation and then redissolved in 3 ml of deionized water and made to pH 5.0 with NaHCO,. The solution was divided and stored frozen at -IO'. The yield of ricinoleoyl-CoA based on the initial amount of CoA was SoyO.
Characterization of ricinoleoyl-CoA
Concentrations of adenine and thiol ester were calculated from absorbances at 260 and 232 nm, respectively, using the extinction coefficients given by SEUBE~T~~. The concentration of thiol ester was also estimated by determining the amount of free CoA liberated from aliquots of the ricinoleoyl-CoA solution by pancreatic lipase14.
Phosphate analyses were performed by the method of EIBL AND LANDS'~ following acid digestion for go min at 190" in the presence of 3 M H&O,.
Aliquots of the ricinoleoyl-Cob solution were transesterified using 0.5 M sodium methoxide in methanol and the resulting methyl esters were extracted into petroleum ether. After evaporation of the solvent under a stream of hi,, 50 /AI of bis-(trimethylsilyl-) trifluoroacetamide was added in order to silylate the hydroxyl groups. After 30 min at 40~so", the silylating reagent was removed under N,, the samples dissolved in 50 ~1 of CS, and analysed by gas-liquid chromato~aphy as described by BRANDT AND LANDS'~. The column temperature was 197~ and the carrier gas used was N,.
Ricinoleic acid was quantitatively determined by hydrolysis of aliquots of the ricinoleoyl-Cob solution using 1.0 ml of 0.1 M NaOH in methanol-water (4: I, v/v) at 80" for 30 min followed by chromatography on thin layers of Silica Gel G with benzene-dioxane-acetic acid-88% formic acid (82 : 14: I : I, by vol.) as the developing solvent. The thin-layer chromatographic plates were sprayed with 500/b H,SO, and charred for 30 min on an electric hotplate. The density of the spots was determined using a Photovolt model 520 recording densitometer fitted with a narrow slit adapter. Recorder response number 5 was used throughout and the amplifier setting was either number I or 2. Before each determination, the zero and full scale values on the recorder were calibrated with the light source at full intensity and at zero intensity, respectively, using an area of the plate on which no spots appeared. Quantitation was achieved via reference to a standard curve generated by an identical procedure using known amounts of ricinoleic acid 17. Peak areas were determined by triangulation in all cases.
Acyltransferase studies
The enzyme preparation used was a washed crude microsomal fraction of rat liver prepared and stored as described by EIBL et al. 18 . Acyl-CoA : I-acyl-sn-glycerol-3-phosphoryl choline acyl-transferase, acyl-CoA : 2-acyl-sn-glycerol-3-phosphoryl choline acyltransferase and acyl-CoA : r-acyl-sn-glycerol-3-phosphate acyl-transferase activities were measured using the spectrophotometric assay system described by LANDS AND HARF'. I-Acyl-sn-glycerol-3-phosphoryl choline was prepared by venom-catalysed hydrolysis of diacyl-sn-glycerol-3-phophoryl choline whereas z-acyl-sn-glycerol-3-phosphoryl choline was prepared by iodine cleavage of I-alkenyl-z-acyl-sn-glycerol--3-phosphoryl choline as described previously20. I-Acyl-sn-glycerol-3-phosphate was prepared by phospholipase D catalysed hydrolysis of I-acyl-sn-glycerol-3-phosphoryl choline (see ref. 20) .
Phosphatidate synthesis from sn-glycerol-3-phosphate was studied using the incubation system described previouslyll with either [3H]glycerol-3-phosphate or [X]oleoyl-CoA.
The lipid products were chromatographed on thin layers of silicic acid using chloroform-ethanol-8S~0 formic acid-water (IOO : II : 3 : 0.25, by vol.) as the developing solvent. Standard preparations of monoacyl-glycerol-3-phosphate and diacyl-glycerol-3-phosphate (prepared by phospholipase hydrolysis of egg lecithin) were added before chromatography. Thin layer chromatographic plates were visualized briefly with I, vapor, decolorized overnight and the fractions were scraped directly into scintillation vials and counted using the fluid system described by SNYDER~~.
RESULTS
Characterization of ricinoleoyl-CoA
Results obtained from the various chemical and enzymatic analyses of ricinoleoyl-CoA and oleoyl-CoA are summarized in Table I . The phosphate: thiol ester : adenine : fatty acid ratios were 3.17 : 1.02 : 1.23 : 1.0 for oleoyl-CoA and 2.68 : 0.88: 0.99 : 1.0 for ricinoleoyl-CoA. These values compare favorably with the 3: I: I: I ratio expected for pure acyl-CoA. Neither acyl-CoA solution contained significant amounts of free CoA as evidenced by the fact that no increase in the absorbance at 413 nm was observed in the absence of pancreatic lipase when aliquots were added to I mM DTNB. After neutralization, the ricinoleic acid was extracted using 4 ml of CHC12-methanol (2: I, v/v). The extract was washed with 4 ml H,O to remove methanol and NaCl and the CHCl, phase was evaporated to dryness. The residue was redissolved in roe ,~l CHCl, and spotted on the thin-layer chromatographic plate. Each point on the standard curve represents the mean & S.D. from four experiments.
The concentration of fatty acid in the two preparations was obtained from data such as those presented in Fig. I for ricinoleoyl-CoA.
The area of the densitometer peaks is plotted as a function of the amount of ricinoleic acid applied to the thin-layer chromatographic plate and also as a function of the volume of the ricinoleoyl-CoA solution (stock solution diluted zo-fold) taken for base hydrolysis and subsequent thin-layer chromatography. A reasonably linear relationship was obtained, and the concentration of ricinoleic acid was calculated from a ratio of the slopes. Oleic acid was similarly determined in basic hydrolysates of a known oleoyl-CoA solution to provide a confirmation of the validity of the methods used.
Densitometric measurements of the commercial ricinoleic acid preparation revealed two impurities representing 6 & 1"/0 of the total mass and travelling with RF values greater than ricinoleate in this solvent system. These impurities could not, however, be detected in basic hydrolysates of the ricinoleoyl-CoA preparation by this technique. Gas-liquid chromatography of the silylated methyl esters arising from either the standard ricinoleic acid preparation or from the ricinoleoyl-Cob failed also 
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to reveal any impurities. No peaks were detected when the silylation procedure was omitted and a single symmetrical peak was observed with either the standard ricinoleic acid sample or the transesterified ricinoleoyl-CoA preparation.
A single peak was also observed when the two samples were co-chromatographed, indicating the presence of a single fatty acid in the ricinoleoyl-CoA preparation which co-chromatographs with authentic ricinoleic acid.
Acyltransfevase studies
The rates of transfer of palmitate, oleate and ricinoleate from their CoA derivatives to the I-and z-isomers of monoacyl-sqlycerol-3-phosphoryl choline and to the I-isomer of monoacyl-sn-glycerol-j-phosphate were studied using the spectrophotometric assay for free CoA release Is. In these experiments, microsomes, buffer, DTNB and acyl-CoA were incubated for several minutes before the addition of acceptor. Acyltransferase rates represent the net change in velocity due to addition of the acceptor. The results of these studies are shown in Tables II and III In agreement with previous reports22~24 the reaction was found to be inhibited by high concentrations of either acyl-CoA or phospholipid acceptor. Therefore, concentrations of acceptors used in these experiments were selected to provide maximal acyltransferase rates in each case. The data in Table II show that ricinoleoyl-CoA served ine~ectively as a substrate in the acylation of either I-or 2-acyl-so-glycerol-3-phosphoryl choline but can, however, serve as an effective substrate for the acylation of I-acyl-sn-glycerol-3-phosphate.
The maximum velocity of incorporation of ricinoleate into diacyl-snglycerol-3-phosphate is comparable to the maximum velocities observed with palmitate and oleate (Table II) , however, the observed K, for ricinoleoyl-Co-4 is about 50,&I under these conditions (Table III) phatidate synthesis from acyl-CoA and sn-glycerol-3-phosphate to see if ricinoleoylCoA could serve as an acyl donor for the acyl-CoA : glycerol-3-phosphate acyltransferase as well.
Studies of phosphatidate synthesis were carried out by incubating microsomes with labelled acyl-CoA or labelled sn-glycerol-3-phosphate as described in methods and chromatographing the products on silicic acid. The plates were divided into x-cm fractions and the fractions scraped into scintillation vials for counting. After the incubations, the extracts from each time point were pooled, chromatographed and counted. Fig. 3 shows the resulting chromatogram obtained from the 4-min incubations. It is clear that the lipid containing ricinoleate moves with an RF different from that containing oleate.
From the data presented in this report, it can be concluded that ricinoleoylCoA is capable of serving as an acyl donor in the acylation of glycerolphosphate or of r-acylglycerolphosphate to form either a di-or mono-ricinoleoyl derivative, respectively. Hence, the evidence suggests that ricinoleate might be incorporated into p~losphoglycerides via the de BOVO~ pathway. In contrast to this finding, the experiments using nlonoac~l-so-glycerol-3-phosphoryl choline as acceptor, suggest that ricinoleate can not enter the lecithin pool via the acyltransferase "retailoring" routeas. Thus these in vitro assays did not give a single, clear explanation for the mechanism by which ricinoleate is excluded from phosphoglycerides in viva. Previous reports have shown that the observed specificity of phosphatidate synthesis in vitro need not be the same as that prevailing in v&o or in tissue slices10~11@~z7. In vitro, the newly synthesized phosphatidate displays a random fatty acid compositionX1 whereas the asymmetric distribution of saturated and unsaturated fatty acids esterified at the I-and a-positions of phosphatidates iw vi& is quite strikingll. Hence, there is reason to believe that the lack of specificity observed in cell-free systems may not reflect accurately that expressed in vivo, although several recent reports have now described non-random acylation in vitro28~28~32~33.
In the spectrophotometric studies, all of the added acyl-CoA appears as free CoA and thus we are seeing essentially 100% of the thiol esters responding to enzymic catalysis. All time curves for CoA release were smooth, with no evidence of any biphasic response. In addition, it can be calculated from the data in Fig. z that 62% of the added ricinoleate was incorporated into diacyl-sn-glycerol-3-phosphate.
Furthermore, the lower RF value for the resultant phosphatidate was expected for a phosphatidate of greater polarity. Thus we can be confident that the conclusions
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drawn from the present data are not due to an impurity, but based on the effects of ricinoleate transfer.
Similar RF values were noted for all time points studied. By comparison with standard lipids (Fig. 3, top) we conclude that diricinoleoyl-sn-glycerol-3-phosphate and dioleoyl-so-glycerol-3-phosphate were formed i.pt vitro. Several papers have indicated that hydroxystearic acid30 and o-hydroxy octadecadienoic acid3i are rapidly converted to non-hydroxy fatty acids in the liver presumably by oxidation to acetate and resynthesis. It would therefore appear that the lifetime of hydroxy fatty acids in this tissue is very short (t,/z < 5 min) and this rapid breakdown perhaps causes a very low steady-state concentration of hydroxy acids in liver. Such a low steady state level in combination with a high K, (such as that seen for the acylation at the z-position) value for ricinoleoyl-Cob in the acylation reaction thus appears to be the most reasonable explanation for the exclusion of ricinoleate from phospholipids in viz10 .
The above hypothesis provides for the exclusion of ricinoleate from the I-and z-positions of all phosphoglycerides, but leaves undetermined the ability of ricinoleoyl-CoA to be esterified to the 3-position of r,z-diacylglycerols.
The enzyme catalyzing that esterification may not be as selective as others (i.e. it may have similar Km values for all acyl-CoA esters). This concept is supported by the appearance of butyrate at the 3-position in milk fats4 and the more abundant long-chain unsaturated acids at that position in liver triacylglycerols35. Even the observation that most long-chain acids appear at the primary position36 could be due to their entry into glycerides at the 3-position. The acylation at the 3-position may be the principal site of entry of rincinoleate into glycerides ifz zlivo. Unfortunately, the opportunity for randomization of the acids at the r-and 3-positions during storage in tissue depots prevents a clear understanding of biosynthetic selectivities from simple analyses of tissue lipid isomers. These studies were supported by US. Public Health Service grant number AM-05310. E. B. is a post-doctoral fellow of National Institutes of Health, fellowship number I-FOz-NS48, 504-01 NSRB and W. S. is supported by U.S. Public Health Service Research Training Grant GM-00187.
